Stephan Herzig
Stephan Herzig is a pharmacologist at the Helmholtz Center Munich, where he studies metabolic processes and their implications on health. His research has contributed to the understanding of how fasting influences hormonal signals and cellular adaptations. Herzig's insights suggest that while intermittent fasting may offer short-term benefits, long-term adherence and weight management play crucial roles in sustaining health improvements.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.07% | +0% | 8,654,622 | 5,883 | $700,000 | 476$ |
| Italy | 1 | 5.00 | 0.03% | +0% | 60,461,826 | 19,007 | $2,000,000 | 629$ |
| Totals | 2 | 69,116,448 | 24,890 | $2,700,000 | 1,105$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Stephan Herzig is a professor at TUM and director of the Institute for Diabetes and Cancer who commented on the risks of intermittent fasting for children and adolescents.
5
Switzerland:
Stephan Herzig, a pharmacologist at the Helmholtz Center Munich, discusses the biological responses to fasting.
5